CHO Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.09	21.81	203.79	505.66	777.98
Short-Term Investments	2,008	2,344	2,399	538.9	538.9
Cash & Short-Term Investments	2,060	2,366	2,603	1,045	1,317
Cash Growth	-12.93%	-9.10%	149.17%	-20.68%	-13.66%
Accounts Receivable	-	0.75	-	-	0.06
Other Receivables	8.03	5.05	2.09	0.09	0.08
Receivables	8.03	5.8	2.09	0.09	0.14
Other Current Assets	55.66	45.68	38.23	34.8	23.62
Total Current Assets	2,124	2,417	2,643	1,079	1,341
Property, Plant & Equipment	26.11	36.43	8.2	19.74	37.23
Other Intangible Assets	420.2	424.8	431.8	497.23	509.93
Other Long-Term Assets	2.68	2.67	3.02	5.84	5.91
Total Assets	2,573	2,881	3,086	1,602	1,894
Accrued Expenses	-	95.75	99.43	150.85	113.04
Current Portion of Leases	14.59	14.31	-	11.7	13.87
Current Unearned Revenue	5.33	-	-	-	-
Other Current Liabilities	89.14	6.12	6.6	6.35	6.31
Total Current Liabilities	109.06	116.19	106.03	168.9	133.22
Long-Term Leases	-	14.59	-	-	11.7
Other Long-Term Liabilities	-	1.8	4.8	4.8	4.8
Total Liabilities	109.06	132.58	110.83	173.7	149.71
Common Stock	2,140	2,140	2,140	1,840	1,839
Additional Paid-In Capital	-	1,130	1,688	135.73	410.58
Retained Earnings	-502.23	-518.31	-850.41	-544.32	-502.76
Comprehensive Income & Other	825.84	-2.7	-2.75	-2.79	-3.25
Shareholders' Equity	2,464	2,749	2,975	1,429	1,744
Total Liabilities & Equity	2,573	2,881	3,086	1,602	1,894
Total Debt	14.59	28.9	-	11.7	25.56
Net Cash (Debt)	2,046	2,337	2,603	1,033	1,291
Net Cash Growth	-12.47%	-10.21%	151.99%	-20.02%	-13.16%
Net Cash Per Share	9.59	10.92	13.60	5.61	7.02
Filing Date Shares Outstanding	212.47	214.01	214.01	183.99	183.94
Total Common Shares Outstanding	212.47	214.01	214.01	183.99	183.94
Working Capital	2,015	2,301	2,537	910.56	1,207
Book Value Per Share	11.60	12.84	13.90	7.76	9.48
Tangible Book Value	2,044	2,324	2,543	931.34	1,234
Tangible Book Value Per Share	9.62	10.86	11.88	5.06	6.71
Machinery	-	112.08	107.99	104.61	96.59
Leasehold Improvements	-	20.72	20.38	19.82	18.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.